Brand Engagement Network (BNAI)announced it has entered into a vendor services project agreement with a global advertising and communications agency for the development of a custom AI engagement communication method for a global pharmaceutical client’s prescription pharmaceutical drug. The identities of the pharmaceutical company and the agency remain confidential pending a formal release of the AI solution. Under the agreement, the company is expected to recognize $250,000 in revenue for development services spanning two statements of work in Q4. Brand Engagement Network anticipates monthly recurring license fees, separate from the development work, in the first quarter of 2026. This development is expected to contribute positively to the Company’s Q4 results.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BNAI:
- Brand Engagement Network Reduces Debt Through Equity Conversions
- Brand Engagement Network reduces liabilities via debt conversion
- Brand Engagement Network Inc trading halted, news pending
- Brand Engagement Network Forms Strategic Healthcare Partnership
- Brand Engagement Network, KOBLOCH, Skye form Skye Salud